A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.
作者信息
Kempker Russell R, Heinrichs M Tobias, Nikolaishvili Ketino, Sabulua Irina, Bablishvili Nino, Gogishvili Shota, Avaliani Zaza, Little Brent P, Bernheim Adam, Derendorf Hartmut, Blumberg Henry M, Vashakidze Sergo, Peloquin Charles A
机构信息
Division of Infectious Diseases, Dept of Medicine, Emory University School of Medicine, Atlanta, GA, USA
University of Florida, College of Pharmacy, Gainesville, FL, USA.
出版信息
Eur Respir J. 2018 Feb 7;51(2). doi: 10.1183/13993003.02166-2017. Print 2018 Feb.
Abstract
摘要
相似文献
1
A comparison of linezolid lung tissue concentrations among patients with drug-resistant tuberculosis.耐多药肺结核患者中利奈唑胺肺组织浓度的比较。
Eur Respir J. 2018 Feb 7;51(2). doi: 10.1183/13993003.02166-2017. Print 2018 Feb.
2
Treatment of multidrug-resistant tuberculosis using therapeutic drug monitoring: first experiences with sub-300 mg linezolid dosages using in-house made capsules.使用治疗药物监测治疗耐多药结核病：使用自制胶囊以低于300毫克利奈唑胺剂量的首次经验。
Eur Respir J. 2019 Dec 4;54(6). doi: 10.1183/13993003.00580-2019. Print 2019 Dec.
3
Linezolid in children with drug resistant tuberculosis.
Infect Dis (Lond). 2018 Nov-Dec;50(11-12):868-870. doi: 10.1080/23744235.2018.1500710. Epub 2018 Oct 8.
4
Proposal for a standardised treatment regimen to manage pre- and extensively drug-resistant tuberculosis cases.关于管理耐多药和广泛耐药结核病病例的标准化治疗方案的提案。
Eur Respir J. 2017 Jul 5;50(1). doi: 10.1183/13993003.00648-2017. Print 2017 Jul.
5
Linezolid in the treatment of drug-resistant tuberculosis: the challenge of its narrow therapeutic index.利奈唑胺治疗耐多药结核病：其治疗指数狭窄带来的挑战
Expert Rev Anti Infect Ther. 2016 Oct;14(10):901-15. doi: 10.1080/14787210.2016.1225498. Epub 2016 Aug 27.
6
Bedaquiline and Linezolid for Extensively Drug-Resistant Tuberculosis in Pregnant Woman.贝达喹啉和利奈唑胺治疗妊娠期广泛耐药结核病。
Emerg Infect Dis. 2017 Oct;23(10):1731-2. doi: 10.3201/eid2310.161398. Epub 2017 Oct 17.
7
Linezolid Pharmacokinetics in South African Patients with Drug-Resistant Tuberculosis and a High Prevalence of HIV Coinfection.利奈唑胺在南非耐药结核病合并高发 HIV 合并感染患者中的药代动力学。
Antimicrob Agents Chemother. 2019 Feb 26;63(3). doi: 10.1128/AAC.02164-18. Print 2019 Mar.
8
Linezolid for Treating Tuberculosis: A Delicate Balancing Act.利奈唑胺治疗结核病：一场微妙的平衡行动。
EBioMedicine. 2015 Oct 21;2(11):1568-9. doi: 10.1016/j.ebiom.2015.10.014. eCollection 2015 Nov.
9
Comparison of the pharmacokinetics of two dosage regimens of linezolid in multidrug-resistant and extensively drug-resistant tuberculosis patients.两种利奈唑胺剂量方案在耐多药和广泛耐药结核病患者中的药代动力学比较。
Clin Pharmacokinet. 2010 Aug;49(8):559-65. doi: 10.2165/11532080-000000000-00000.
10
Pharmacokinetics of moxifloxacin and linezolid during and after pregnancy in a patient with multidrug-resistant tuberculosis.耐多药肺结核患者孕期及产后莫西沙星和利奈唑胺的药代动力学
Eur Respir J. 2017 Mar 22;49(3). doi: 10.1183/13993003.01724-2016. Print 2017 Mar.
引用本文的文献
1
Model-based translation of the PKPD-relationship for linezolid and vancomycin on methicillin-resistant Staphylococcus aureus: from in vitro time-kill experiments to a mouse pneumonia model.基于模型的利奈唑胺和万古霉素对耐甲氧西林金黄色葡萄球菌的药代动力学-药效学关系翻译：从体外时间杀菌实验到小鼠肺炎模型
J Antimicrob Chemother. 2025 Jul 1;80(7):1860-1868. doi: 10.1093/jac/dkaf140.
2
Differential distribution of linezolid in diseased and nondiseased bones in patients with spinal tuberculosis.利奈唑胺在脊柱结核患者病变和非病变骨中的差异分布。
BMC Infect Dis. 2024 Jan 5;24(1):50. doi: 10.1186/s12879-023-08970-x.
3
Mycobacterium tuberculosis sterilizing activity of faropenem, pyrazinamide and linezolid combination and failure to shorten the therapy duration.氟喹诺酮类药物、吡嗪酰胺和利奈唑胺联合使用对结核分枝杆菌的杀菌活性及不能缩短治疗时间。
Int J Infect Dis. 2021 Mar;104:680-684. doi: 10.1016/j.ijid.2021.01.062. Epub 2021 Feb 5.
4
Model-Informed Drug Development for Anti-Infectives: State of the Art and Future.基于模型的抗感染药物研发：现状与未来。
Clin Pharmacol Ther. 2021 Apr;109(4):867-891. doi: 10.1002/cpt.2198. Epub 2021 Mar 9.
5
Distribution of Linezolid in Tuberculosis Lesions in Patients with Spinal Multidrug-Resistant Tuberculosis.利奈唑胺在脊柱耐多药结核患者结核病变中的分布。
Antimicrob Agents Chemother. 2020 Jun 23;64(7). doi: 10.1128/AAC.00450-20.
6
Penetration of linezolid into bone tissue 24 h after administration in patients with multidrug-resistant spinal tuberculosis.利奈唑胺在耐多药脊柱结核患者给药 24 小时后进入骨组织的渗透。
PLoS One. 2019 Oct 3;14(10):e0223391. doi: 10.1371/journal.pone.0223391. eCollection 2019.
7
Linezolid-induced pure red cell aplasia: a case report and literature review.利奈唑胺诱导的纯红细胞再生障碍：一例病例报告及文献综述。
J Int Med Res. 2018 Nov;46(11):4837-4844. doi: 10.1177/0300060518800126. Epub 2018 Oct 1.
本文引用的文献
1
Linezolid Dose That Maximizes Sterilizing Effect While Minimizing Toxicity and Resistance Emergence for Tuberculosis.利奈唑胺剂量：在使结核病的杀菌效果最大化的同时，将毒性和耐药性出现降至最低
Antimicrob Agents Chemother. 2017 Jul 25;61(8). doi: 10.1128/AAC.00751-17. Print 2017 Aug.
2
Lung Tissue Concentrations of Pyrazinamide among Patients with Drug-Resistant Pulmonary Tuberculosis.耐多药肺结核患者肺组织中吡嗪酰胺的浓度
Antimicrob Agents Chemother. 2017 May 24;61(6). doi: 10.1128/AAC.00226-17. Print 2017 Jun.
3
Cavitary penetration of levofloxacin among patients with multidrug-resistant tuberculosis.左氧氟沙星在耐多药结核病患者中的空洞穿透情况。
Antimicrob Agents Chemother. 2015;59(6):3149-55. doi: 10.1128/AAC.00379-15. Epub 2015 Mar 16.
4
Favorable outcomes for multidrug and extensively drug resistant tuberculosis patients undergoing surgery.多药和广泛耐药结核病患者手术治疗的良好结局。
Ann Thorac Surg. 2013 Jun;95(6):1892-8. doi: 10.1016/j.athoracsur.2013.03.067. Epub 2013 May 1.
5
Efficacy, safety and tolerability of linezolid containing regimens in treating MDR-TB and XDR-TB: systematic review and meta-analysis.利奈唑胺方案治疗耐多药结核病和广泛耐药结核病的疗效、安全性和耐受性：系统评价和荟萃分析。
Eur Respir J. 2012 Dec;40(6):1430-42. doi: 10.1183/09031936.00022912. Epub 2012 Apr 10.
6
Additional drug resistance in Mycobacterium tuberculosis isolates from resected cavities among patients with multidrug-resistant or extensively drug-resistant pulmonary tuberculosis. 耐多药或广泛耐药肺结核患者切除空洞中分离的结核分枝杆菌分离株的额外耐药性。
Clin Infect Dis. 2012 Mar;54(6):e51-4. doi: 10.1093/cid/cir904. Epub 2011 Dec 23.
7
Wild-type distributions of seven oral second-line drugs against Mycobacterium tuberculosis.七种抗结核分枝杆菌二线口服药物的野生型分布。
Int J Tuberc Lung Dis. 2011 Apr;15(4):502-9. doi: 10.5588/ijtld.10.0238.
8
Pharmacokinetics and intrapulmonary concentrations of linezolid administered to critically ill patients with ventilator-associated pneumonia.利奈唑胺用于治疗呼吸机相关性肺炎重症患者的药代动力学及肺内浓度
Crit Care Med. 2005 Jul;33(7):1529-33. doi: 10.1097/01.ccm.0000168206.59873.80.
9
Mutant prevention concentration: comparison of fluoroquinolones and linezolid with Mycobacterium tuberculosis.突变预防浓度：氟喹诺酮类药物与利奈唑胺对结核分枝杆菌的比较
J Antimicrob Chemother. 2004 Mar;53(3):441-4. doi: 10.1093/jac/dkh119. Epub 2004 Feb 12.
10
Clinical pharmacokinetics of linezolid, a novel oxazolidinone antibacterial.新型恶唑烷酮类抗菌药物利奈唑胺的临床药代动力学
Clin Pharmacokinet. 2003;42(13):1129-40. doi: 10.2165/00003088-200342130-00004.
Zotero 插件